Article
Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis.
Journal of musculoskeletal & neuronal interactions - 1 Mar 2015
Hooker R A, Chitteti B R, Egan P H, Cheng Y H, Himes E R, Meijome T, Srour E F, Fuchs R K, Kacena M A
Abstract excerpt
Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), is expressed on osteoblasts (OB) and hematopoietic stem cells (HSC) residing in the hematopoietic niche, and may have important regulatory roles in bone formation. Because HSC numbers are reduced 77% in CD166(-/-) mice, we hypothesized tha...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
